Company: LHI
Filing Date: 2025-11-20
Form Type: F-1/A
Source: 0001213900-25-112807
Chunk: 174

Company: Living Homeopathy International Ltd.
Filing Date: 2025-11-20
Form: F-1/A
Chunk 174
---
 grant a waiver of the 
 code of business conduct and ethics to directors and officers.                                                                    |

| ● | Exemption from the requirement                                                                                            
 to obtain shareholder approval for certain issuances of securities, including shareholder approval of stock option plans. |

<div align='center'>97</div>

| ● | Exemption from the requirements                                                                                                  
 governing the review and oversight of all “related party transactions,” as defined in Item 7.B of Form 20-F.                     |
| ● | Exemption from the requirement                                                                                                   
 that our board of directors shall have regularly scheduled meetings at which only independent directors are present as set forth 
 in Nasdaq Rule 5605(b)(2).                                                                                                       |

Although we mayrely on home country corporate governance practices in lieu of certain of the rules in the Nasdaq Rule 5600 Series and Rule 5250(d), we must comply with Nasdaq’s Notification of Noncompliance requirement (Rule 5625), the Voting Rights requirement (Rule 5640) and have an audit committee that satisfies Rule 5605(c)(3), consisting of committee members that meet the independence requirements of Rule 5605(c)(2)(A)(ii).

In addition, as a foreign private issuer, we expect to take advantage of the following exemptions from SEC reporting obligations:

| ● | Exemption from filing quarterly                                                                                                  
 reports on Form 10-Q or provide current reports on Form 8-K, disclosing significant events within four days of their occurrence. |

| ● | Exemption from Section                                                                                                                 
 16 rules regarding sales of common shares by insiders, which will provide less data in this regard than shareholders of U.S. companies 
 that are subject to the Exchange Act.                                                                                                  |

Accordingly, our shareholders will not have the same protections afforded to shareholders of companies that are mandatorily subject to all of the corporate governance requirements of Nasdaq and the domestic reporting requirements of the SEC. We may utilize these exemptions for as long as we continue to qualify as a foreign private issuer.

Interested Transactions

Interested director transactions are governed by the terms of a company’s memorandum and articles of association.

A director may, subject to any separate requirement for audit committee approval under applicable law, the Amended and Restated Memorandum and Articles of Association or the Nasdaq Stock Market Listing Rules, or disqualification by the chairman of the relevant board meeting, vote in respect of certain contract or transaction in which he or she is interested, provided that the nature of the interest of any directors in such contract or